{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T03:14:17Z","timestamp":1793070857390,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007048","name":"Mayo Foundation for Medical Education and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.humpath.2025.105797","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T19:20:57Z","timestamp":1747336857000},"page":"105797","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Evaluation of 3,606 renal cell tumors for TFE3 rearrangements and TFEB alterations via fluorescence in situ hybridization, next generation sequencing, and GPNMB immunohistochemistry"],"prefix":"10.1016","volume":"159","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9256-4484","authenticated-orcid":false,"given":"Rumeal D.","family":"Whaley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R.","family":"Sill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burak","family":"Tekin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micheal R.","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Cheville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kingsley","family":"Ebare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa L.","family":"Stanton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan P.","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Raghunathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loren P.","family":"Herrera Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael E.","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidit","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen A.","family":"Boorjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley C.","family":"Leibovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Hofich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saba","family":"Alvand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh P.","family":"Pujari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin R.","family":"Kipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhett P.","family":"Ketterling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine B.","family":"Geiersbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia T.","family":"Greipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Sukov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin C.","family":"Halling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5163-6955","authenticated-orcid":false,"given":"Sounak","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2025.105797_bib1","series-title":"Urinary and male genital tumors. vol. 8. 5th ed.","year":"2022"},{"key":"10.1016\/j.humpath.2025.105797_bib2","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/his.13167","article-title":"Incidence, clinicopathological features and fusion transcript landscape of translocation renal cell carcinomas","volume":"70","author":"Classe","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2025.105797_bib3","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/PAS.0b013e31824dd972","article-title":"TFE3 rearrangements in adult renal cell carcinoma: clinical and pathologic features with outcome in a large series of consecutively treated patients","volume":"36","author":"Sukov","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.105797_bib4","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1158\/1078-0432.CCR-08-1183","article-title":"Adult Xp11 translocation renal cell carcinoma diagnosed by cytogenetics and immunohistochemistry","volume":"15","author":"Komai","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2025.105797_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1017425","article-title":"Clinicopathological features and prognosis of TFE3-positive renal cell carcinoma","volume":"12","author":"Dong","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.humpath.2025.105797_bib6","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/PAS.0b013e31824f24a6","article-title":"Translocation renal cell carcinomas in adults: a single-institution experience","volume":"36","author":"Zhong","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.105797_bib7","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/his.14634","article-title":"Renal cell carcinoma in children and adolescents: a retrospective study of a French\u2013Italian series of 93 cases","volume":"80","author":"Denize","year":"2022","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2025.105797_bib8","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1002\/cncr.31578","article-title":"The classification of pediatric and young adult renal cell carcinomas registered on the children's oncology group (COG) protocol AREN03B2 after focused genetic testing","volume":"124","author":"Cajaiba","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2025.105797_bib9","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1097\/PAS.0000000000000720","article-title":"TFEB-Amplified renal cell carcinomas: an aggressive molecular subset demonstrating variable melanocytic marker expression and morphologic heterogeneity","volume":"40","author":"Argani","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.105797_bib10","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1097\/PAS.0000000000001307","article-title":"TFEB expression profiling in renal cell carcinomas: clinicopathologic correlations","volume":"43","author":"Gupta","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.105797_bib11","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/ajcp\/aqad089","article-title":"Lessons from 801 clinical TFE3\/TFEB fluorescence in situ hybridization assays performed on renal cell carcinoma suspicious for MiTF family aberrations","volume":"160","author":"Wang","year":"2023","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2025.105797_bib12","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/PAS.0000000000000776","article-title":"Renal cell carcinoma with chromosome 6p amplification including the TFEB gene: a novel mechanism of tumor pathogenesis?","volume":"41","author":"Williamson","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.105797_bib13","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1097\/PAS.0b013e3182613d8f","article-title":"Molecular confirmation of t(6;11)(p21;q12) renal cell carcinoma in archival paraffin-embedded material using a break-apart TFEB FISH assay expands its clinicopathologic spectrum","volume":"36","author":"Argani","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.105797_bib14","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/PAS.0b013e318031ffff","article-title":"Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum","volume":"31","author":"Argani","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.105797_bib15","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1097\/PAS.0000000000001541","article-title":"Morphologic and immunohistochemical characteristics of fluorescent in situ hybridization confirmed TFE3-gene fusion associated renal cell carcinoma: a single institutional cohort","volume":"44","author":"Akgul","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.105797_bib16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.humpath.2019.02.008","article-title":"Immunohistochemistry for TFE3 lacks specificity and sensitivity in the diagnosis of TFE3-rearranged neoplasms: a comparative, 2-laboratory study","volume":"87","author":"Sharain","year":"2019","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2025.105797_bib17","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/jclinpath-2020-207372","article-title":"Diagnostic approach in TFE3-rearranged renal cell carcinoma: a multi-institutional international survey","volume":"74","author":"Akgul","year":"2021","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.humpath.2025.105797_bib18","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000146007.54092.37","article-title":"Renal carcinomas with the t(6;11)(p21;q12): clinicopathologic features and demonstration of the specific alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA PCR","volume":"29","author":"Argani","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.105797_bib19","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/PAS.0b013e31818fbdff","article-title":"Melanotic Xp11 translocation renal cancers: a distinctive neoplasm with overlapping features of PEComa, carcinoma, and melanoma","volume":"33","author":"Argani","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.105797_bib20","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1097\/00000478-200212000-00003","article-title":"PRCC-TFE3 renal carcinomas: morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1)(p11.2;q21)","volume":"26","author":"Argani","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.105797_bib21","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/PAS.0000000000000835","article-title":"RBM10-TFE3 renal cell carcinoma: a potential diagnostic pitfall due to cryptic intrachromosomal Xp11.2 inversion resulting in false-negative TFE3 FISH","volume":"41","author":"Argani","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.105797_bib22","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1097\/PAS.0b013e3181e8ce5b","article-title":"Xp11 translocation renal cell carcinoma (RCC): extended immunohistochemical profile emphasizing novel RCC markers","volume":"34","author":"Argani","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.105797_bib23","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/PAS.0000000000000631","article-title":"TFE3-Fusion variant analysis defines specific clinicopathologic associations among Xp11 translocation cancers","volume":"40","author":"Argani","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.105797_bib24","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/PAP.0000000000000332","article-title":"Chameleon TFE3-translocation RCC and how gene partners can change morphology: accurate diagnosis using contemporary modalities","volume":"29","author":"Tretiakova","year":"2022","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.humpath.2025.105797_bib25","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00428-022-03380-x","article-title":"TFE3 and TFEB-rearranged renal cell carcinomas: an immunohistochemical panel to differentiate from common renal cell neoplasms","volume":"481","author":"Cali\u00f2","year":"2022","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2025.105797_bib26","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/path.5875","article-title":"GPNMB expression identifies TSC1\/2\/mTOR-associated and MiT family translocation-driven renal neoplasms","volume":"257","author":"Salles","year":"2022","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2025.105797_bib27","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jmoldx.2024.10.004","article-title":"SARCP, a clinical next-generation sequencing assay for the detection of gene fusions in sarcomas: a description of the first 652 cases","volume":"27","author":"Atiq","year":"2025","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.humpath.2025.105797_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.humpath.2023.12.006","article-title":"Next generation sequencing-based identification of fusion-driven renal neoplasia: a single institution experience","volume":"152","author":"Tekin","year":"2024","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2025.105797_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.humpath.2024.105654","article-title":"Expanding the spectrum of fusion partners for cystic TFE3-rearranged renal cell carcinomas: a report of a MAPK1IP1L::TFE3-rearranged renal cell carcinoma","volume":"153","author":"Tekin","year":"2024","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2025.105797_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16193396","article-title":"TFE3-Rearranged tumors of the kidney: an emerging conundrum","volume":"16","author":"Cali\u00f2","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.humpath.2025.105797_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2024.07.038","article-title":"A genetic basis for sex differences in Xp11 translocation renal cell carcinoma","author":"Achom","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.humpath.2025.105797_bib32","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.anndiagpath.2014.10.002","article-title":"Aggressive and nonaggressive translocation t(6;11) renal cell carcinoma: comparative study of 6 cases and review of the literature","volume":"18","author":"Peckova","year":"2014","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.humpath.2025.105797_bib33","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1097\/PAS.0b013e31828a69ae","article-title":"Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service","volume":"37","author":"Green","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.105797_bib34","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/modpathol.2013.83","article-title":"Molecular cytogenetic analysis for TFE3 rearrangement in Xp11.2 renal cell carcinoma and alveolar soft part sarcoma: validation and clinical experience with 75 cases","volume":"27","author":"Hodge","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2025.105797_bib35","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/modpathol.2017.24","article-title":"TFEB-VEGFA (6p21.1) co-amplified renal cell carcinoma: a distinct entity with potential implications for clinical management","volume":"30","author":"Gupta","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2025.105797_bib36","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/modpathol.2016.204","article-title":"Xp11.2 translocation renal cell carcinoma with NONO-TFE3 gene fusion: morphology, prognosis, and potential pitfall in detecting TFE3 gene rearrangement","volume":"30","author":"Xia","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2025.105797_bib37","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1038\/s41379-021-00858-y","article-title":"Diagnostic utility of one-stop fusion gene panel to detect TFE3\/TFEB gene rearrangement and amplification in renal cell carcinomas","volume":"34","author":"Harada","year":"2021","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2025.105797_bib38","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/s41379-020-00713-6","article-title":"TFEB rearranged renal cell carcinoma. A clinicopathologic and molecular study of 13 cases. Tumors harboring MALAT1-TFEB, ACTB-TFEB, and the novel NEAT1-TFEB translocations constantly express PDL1","volume":"34","author":"Cali\u00f2","year":"2021","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2025.105797_bib39","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/00000478-200306000-00005","article-title":"Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay","volume":"27","author":"Argani","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.105797_bib40","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/PAS.0b013e3181609914","article-title":"Renal translocation carcinomas: clinicopathologic, immunohistochemical, and gene expression profiling analysis of 31 cases with a review of the literature","volume":"32","author":"Camparo","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.105797_bib41","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/s41379-018-0191-7","article-title":"NEAT1-TFE3 and KAT6A-TFE3 renal cell carcinomas, new members of MiT family translocation renal cell carcinoma","volume":"32","author":"Pei","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2025.105797_bib42","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/PAS.0000000000000203","article-title":"t(6;11) renal cell carcinoma (RCC): expanded immunohistochemical profile emphasizing novel RCC markers and report of 10 new genetically confirmed cases","volume":"38","author":"Smith","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.105797_bib43","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/his.14663","article-title":"Eosinophilic solid and cystic renal cell carcinoma and renal cell carcinomas with TFEB alterations: a comparative study","volume":"81","author":"Lobo","year":"2022","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2025.105797_bib44","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/gcc.23127","article-title":"A novel VCP::TFE3 gene fusion resulting from t(X;9)(p11.23;p13.3) chromosome translocation in TFE3 rearranged renal cancer cell carcinoma","volume":"62","author":"Kuentz","year":"2023","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.humpath.2025.105797_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2023.100404","article-title":"Molecular characterization of TFE3-rearranged renal cell carcinoma: a comparative study with papillary and clear cell renal cell carcinomas","volume":"37","author":"Wei","year":"2024","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2025.105797_bib46","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12943-024-02044-5","article-title":"Patients with ASPSCR1-TFE3 fusion achieve better response to ICI based combination therapy among TFE3-rearranged renal cell carcinoma","volume":"23","author":"Zhao","year":"2024","journal-title":"Mol Cancer"},{"key":"10.1016\/j.humpath.2025.105797_bib47","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/PAS.0000000000001408","article-title":"Clinicopathologic and molecular analysis of the TFEB fusion variant reveals new members of TFEB translocation renal cell carcinomas (RCCs): expanding the genomic spectrum","volume":"44","author":"Xia","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.105797_bib48","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13046-023-02667-4","article-title":"High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinoma","volume":"42","author":"Lang","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.humpath.2025.105797_bib49","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1177\/10668969231185077","article-title":"A TFEB-amplified renal cell carcinoma with long-term, complete immunotherapy response: retrospective support for the value of molecular classification","volume":"32","author":"Smith","year":"2024","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.105797_bib50","doi-asserted-by":"crossref","first-page":"6827","DOI":"10.1158\/1078-0432.CCR-19-0733","article-title":"TFEB mediates immune evasion and resistance to mTOR inhibition of renal cell carcinoma via induction of PD-L1","volume":"25","author":"Zhang","year":"2019","journal-title":"Clin Cancer Res"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004681772500084X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004681772500084X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T04:28:59Z","timestamp":1749270539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004681772500084X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":50,"alternative-id":["S004681772500084X"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2025.105797","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of 3,606 renal cell tumors for TFE3 rearrangements and TFEB alterations via fluorescence in situ hybridization, next generation sequencing, and GPNMB immunohistochemistry","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2025.105797","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105797"}}